Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02059902 · ClinicalTrials.gov registry record · Phase 4
Continuous Lidocaine Infusion for Management of Perioperative Burn Pain
A Phase 4 study of Thermal Burns, sponsored by HealthPartners Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT02059902: Completed Phase 4 study of Thermal Burns, sponsored by HealthPartners Institute.
NCT02059902 is a Phase 4 study of Thermal Burns that has completed, run by HealthPartners Institute. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02059902, a Phase 4 study of Thermal Burns, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Thermal injury results in one of the most intense and prolonged forms of pain the body can experience. Opioid narcotics are the most powerful drugs for acute and chronic pain, and their use in the perioperative period has been the mainstay of treatment; although medication requirements in burn patients are often underestimated. More medication may not be the answer, as relatively large doses of short acting opioids in the operative theater are associated with greater postoperative opioid consumption and higher pain scores. Furthermore, extensive use of opioids has resulted in the development of by hyperalgesia and allodynia. Lidocaine is an amide local anesthetic that has analgesic, anti-hyperalgesic, antiarrhythmic, and anti-inflammatory properties. Over the past 25 years, systemic lidocaine has been used for perioperative pain management in a variety of surgical procedures. The design of this study will examine if lidocaine will reduce the pain scores and narcotic utilization in patients undergoing surgical procedures for burn injuries. The intervention group will receive a bolus dose of lidocaine followed by a continuous infusion over 24 hours. The control group will get an equal volume of saline. The investigators will compare pain scores, opioid use, and narcotic equivalents based on body weight and burn surface area (BSA) grafted.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Lidocaine
Study Locations (1)
Minnesota
- Regions Hospital - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2012-09 |
| Est. Completion | 2015-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02059902
The ClinicalTrials.gov registry entry for NCT02059902 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thermal Burns appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02059902 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02059902 about?
NCT02059902 is a clinical study titled "Continuous Lidocaine Infusion for Management of Perioperative Burn Pain". Thermal injury results in one of the most intense and prolonged forms of pain the body can experience. Opioid narcotics are the most powerful drugs for acute and chronic pain, and their use in the perioperative period has been the mainstay of treatment; although medication requirements in burn patie...
What is the current status of trial NCT02059902?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2012-09. Estimated completion is 2015-02.
What conditions does trial NCT02059902 study?
This clinical trial studies the following conditions: Thermal Burns.
What interventions are being tested in trial NCT02059902?
The interventions under investigation include: Placebo (OTHER), Lidocaine (DRUG).
Who is sponsoring clinical trial NCT02059902?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02059902 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thermal Burns
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.